Concepedia
Statistics
Publications
40
Citations
1.8K
H-Index
25
Active since
2002
Affiliations
Amgen (United States)(Current)
Pfizer (United States)
University of Washington
R. Foti is an author at Amgen (United States) specializing in pharmacology, medicine, and cytochrome p450 enzymes.
Publications per year
2002–2019
Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs
R. Foti, Michael B. Fisher · Forensic Science International · 2005 · 135 citations
Life Sciences, Biochemistry, Molecular Biology +9
Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo Simulation
R. Foti, Dan A. Rock, Larry C. Wienkers et al. · Drug Metabolism and Disposition · 2010 · 130 citations
Medicine, Pharmacokinetics, Pharmacology +17
Cytochrome P450 and Non–Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics
R. Foti, Deepak Dalvie · Drug Metabolism and Disposition · 2016 · 112 citations
Medicine, Pharmacokinetics, Pharmacology +12
Fluoxetine- and Norfluoxetine-Mediated Complex Drug–Drug Interactions: In Vitro to In Vivo Correlation of Effects on CYP2D6, CYP2C19, and CYP3A4
Jennifer E. Sager, J. Lutz, R. Foti et al. · Clinical Pharmacology & Therapeutics · 2014 · 82 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Prediction of CYP2D6 Drug Interactions from In Vitro Data: Evidence for Substrate-Dependent Inhibition
Brooke M. VandenBrink, R. Foti, Dan A. Rock et al. · Drug Metabolism and Disposition · 2011 · 79 citations
1–5 of 40